Evidence map›Paper›PMID 42470288›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Giant Anisotropy and High Second-Order Nonlinearity of 3R-MoS

Georgy Ermolaev, Dmitriy Grudinin, Liudmila Klimova, Adilet Toksumakov, Mikhail Gubin, Anton Minnekhanov, Aleksandr Slavich, Mikhail Mironov, Arslan Mazitov, Dmitry Yakubovsky and 8 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Georgy ErmolaevEmerging Technologies Research Center, XPANCEO, Dubai, UAE.ORCID https://orcid.org/0000-0002-0895-818X
Dmitriy GrudininEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Liudmila KlimovaEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Adilet ToksumakovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Mikhail GubinEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Anton MinnekhanovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Aleksandr SlavichEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Mikhail MironovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Arslan MazitovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Dmitry YakubovskyEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Nikolay PakEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Andrey VyshnevyyEmerging Technologies Research Center, XPANCEO, Dubai, UAE.ORCID https://orcid.org/0000-0003-1394-4169
Ivan KruglovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Gleb TselikovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Alexei ProkhorovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.
Aleksey ArseninEmerging Technologies Research Center, XPANCEO, Dubai, UAE.ORCID https://orcid.org/0000-0002-7506-4389
Kostya S NovoselovDepartment of Materials Science and Engineering, National University of Singapore, Singapore, Singapore.
Valentyn VolkovEmerging Technologies Research Center, XPANCEO, Dubai, UAE.

Funding

Ministry of EducationNational Research Foundation AISG3-RP-2022-028
6 · The paper itself

Abstract

The miniaturization of photonic circuits is impeded by the difficulty of combining active nonlinear frequency conversion with passive subdiffractional light guiding. Here, we establish a rhombohedral 3R-polytype of MoS

Indexed as

diffractionmaterials sciencenanophotonicsopticsoptoelectronicsphotonicspoint reflectionrefractive indexresonator

Identifiers

PMID42470288
PMCPMC13508744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.